FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 334:186-188 January 18, 1996 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Breast cancer is the most common cancer among women in the Western world, with a cumulative lifetime risk of 1 in 8.¹ The two strongest risk factors are age and a family history of breast cancer. Five years ago, a region on chromosome 17 was shown by linkage analysis to have a substantial role in early-onset familial breast and ovarian cancer.² An intense gene-hunting effort of the "positional cloning" type³ culminated in the identification of the BRCA1 gene in the fall of 1994.^4,5 These results will require that all physicians who care for patients understand the molecular genetics of breast . . . [Full Text of this Article]

References

Related Letters:

Genetic Screening for Breast Cancer
Rosenblatt D. S., Foulkes W. D., Narod S. A., Collins F. S.
Extract | Full Text  
N Engl J Med 1996; 334:1200-1201, May 2, 1996. Correspondence

This article has been cited by other articles:

• Kell, M. R, Burke, J. P (2007). Management of breast cancer in women with BRCA gene mutation. BMJ 334: 437-438 [Full Text]  
• de Melo-Martin, I (2005). Firing up the nature/nurture controversy: bioethics and genetic determinism. J. Med. Ethics 31: 526-530 [Abstract] [Full Text]  
• Green, M. J., Botkin, J. R. (2003). "Genetic Exceptionalism" in Medicine: Clarifying the Differences between Genetic and Nongenetic Tests. ANN INTERN MED 138: 571-575 [Abstract] [Full Text]  
• Fleming, M. A., Potter, J. D., Ramirez, C. J., Ostrander, G. K., Ostrander, E. A. (2003). Understanding missense mutations in the BRCA1 gene: An evolutionary approach. Proc. Natl. Acad. Sci. USA 100: 1151-1156 [Abstract] [Full Text]  
• Chen, W. Y., Garber, J. E., Higham, S., Schneider, K. A., Davis, K. B., Deffenbaugh, A. M., Frank, T. S., Gelman, R. S., Li, F. P. (2002). BRCA1/2 Genetic Testing in the Community Setting. JCO 20: 4485-4492 [Abstract] [Full Text]  
• Helmes, A. W., Bowen, D. J., Bowden, R., Bengel, J. (2000). Predictors of Participation in Genetic Research in a Primary Care Physician Network. Cancer Epidemiol. Biomarkers Prev. 9: 1377-1379 [Abstract] [Full Text]  
• Armstrong, K., Calzone, K., Stopfer, J., Fitzgerald, G., Coyne, J., Weber, B. (2000). Factors Associated with Decisions about Clinical BRCA1/2 Testing. Cancer Epidemiol. Biomarkers Prev. 9: 1251-1254 [Abstract] [Full Text]  
• Wang, P.-H., Shyong, W.-Y., Li, Y. F., Lee, H.-H., Tsai, W.-Y., Chao, H.-T., Wu, C.-Y., Tsai, Y.-C., Yuan, C.-C. (2000). BRCA1 Mutations in Taiwanese with Epithelial Ovarian Carcinoma and Sporadic Primary Serous Peritoneal Carcinoma. Jpn J Clin Oncol 30: 343-348 [Abstract] [Full Text]  
• Aktan-Collan, K., Mecklin, J.-P., de la Chapelle, A., Peltomäki, P., Uutela, A., Kääriäinen, H. (2000). Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer. J. Med. Genet. 37: 108-113 [Abstract] [Full Text]  
• Rothfuss, A., Schütz, P., Bochum, S., Volm, T., Eberhardt, E., Kreienberg, R., Vogel, W., Speit, G. (2000). Induced Micronucleus Frequencies in Peripheral Lymphocytes as a Screening Test for Carriers of a BRCA1 Mutation in Breast Cancer Families. Cancer Res. 60: 390-394 [Abstract] [Full Text]  
• Newman, B., Mu, H., Butler, L. M., Millikan, R. C., Moorman, P. G., King, M.-C. (1998). Frequency of Breast Cancer Attributable to BRCA1 in a Population-Based Series of American Women. JAMA 279: 915-921 [Abstract] [Full Text]  
• Kodish, E., Wiesner, G. L., Mehlman, M., Murray, T. (1998). Genetic Testing for Cancer Risk: How to Reconcile the Conflicts. JAMA 279: 179-181 [Full Text]  
• Wilfond, B. S., Rothenberg, K. H., Thomson, E. J., Lerman, C. (1997). Cancer Genetic Susceptibility Testing: Ethical and Policy Implications for Future Research and Clinical Practice. J Law Med Ethics 25: 243-251  
• Ponder, B. (1997). Genetic Testing for Cancer Risk. Science 278: 1050-1054 [Abstract] [Full Text]  
• Humphrey, J. S., Salim, A., Erdos, M. R., Collins, F. S., Brody, L. C., Klausner, R. D. (1997). Human BRCA1 inhibits growth in yeast: Potential use in diagnostic testing. Proc. Natl. Acad. Sci. USA 94: 5820-5825 [Abstract] [Full Text]  
• Healy, B. (1997). BRCA Genes -- Bookmaking, Fortunetelling, and Medical Care. NEJM 336: 1448-1449 [Full Text]  
• Petty, E. M., Killeen, A. A. (1997). BRCA1 Mutation Testing: Controversies and Challenges. Clin. Chem. 43: 6-8 [Full Text]  
• Rohlfs, E. M., Learning, W. G., Friedman, K. J., Couch, F. J., Weber, B. L., Silverman, L. M. (1997). Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis. Clin. Chem. 43: 24-29 [Abstract] [Full Text]  
• Hubbard, R., Lewontin, R.C. (1996). Pitfalls of Genetic Testing. NEJM 334: 1192-1194 [Full Text]  
• Offit, K., Mathew, C. G., Solomon, E., Hodgson, S. V., Ithier, G., Girard, M., Stoppa-Lyonnet, D., Sher, C., Sharabani-Gargir, L., Shohat, M., Haber, D. A., Garber, J. E., Finkelstein, D. M., Langston, A. A., Malone, K. E., Ostrander, E. A. (1996). Breast Cancer and BRCA1 Mutations. NEJM 334: 1197-1200 [Full Text]  
• Rosenblatt, D. S., Foulkes, W. D., Narod, S. A., Collins, F. S. (1996). Genetic Screening for Breast Cancer. NEJM 334: 1200-1201 [Full Text]